Side-by-side comparison of AI visibility scores, market position, and capabilities
Credit rating and analytics duopolist with $7.1B FY2024 revenue; Berkshire Hathaway ~12% stake; 50%+ MIS operating margins; generative AI tools for credit analysis; RMS catastrophe risk acquisition.
Moody's Corporation is a global integrated risk assessment firm and the parent of Moody's Investors Service (MIS), one of the world's two largest credit rating agencies, and Moody's Analytics (MA), a leading provider of financial intelligence and analytical tools, founded in 1909 by John Moody in New York City, where it remains headquartered and trades on NYSE (MCO). The company generated approximately $7.1 billion in revenues for FY2024 under CEO Rob Fauber, with Moody's Investors Service benefiting from elevated debt issuance volumes driven by corporate refinancing activity, CLO formation, and infrastructure financing, while Moody's Analytics delivered high single-digit growth from recurring subscription revenues in its banking, insurance, and corporate risk management software platforms. Berkshire Hathaway owns approximately 12% of Moody's shares, a long-term holding reflecting Warren Buffett's appreciation for the company's near-duopoly pricing power in credit ratings.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.